Proxy Votes Now

Home › Funds › Vanguard › Vanguard Extended Market Index Fund

Vanguard Extended Market Index Fund (VXF) proxy voting record 2025-2026

Fund family: Vanguard · Filed by VANGUARD INDEX FUNDS (CIK 36405) · SEC series S000002841

Share classes and tickers: VXF (C000007782), VEMPX (C000096110), VEXAX (C000007780), VEXMX (C000007779), VIEIX (C000007781), VSEMX (C000170275)

2023-20242024-20252025-2026

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 35,922 with, 8,953 against, 705 abstentions (not counted as with management); 71 items carried no recommendation; 4,878 split votes are in neither count. Shareholder proposals: 25 FOR, 88 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Vanguard as a whole

The same two figures as Vanguard’s manager page (1,379,791 ballot items across 136 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsVanguardItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)91.5%44,30294.5%1,082,514
Backed environmental and social shareholder proposals at US companiesn/a260.9%6,718

Where this fund voted differently from most Vanguard funds

Each ballot item this fund voted is set against the votes of the other Vanguard funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Vanguard funds on 170 items (0.6% of the 28,668 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Vanguard fundsMgmtResult
Pacira Biosciences, Inc.2026-06-09Approval of our Amended and Restated 2011 Stock Incentive Plan.AgainstFOR — 18 of 20 Vanguard fundsAgainstFailed (calculated), 43.5% support
Vir Biotechnology, Inc.2026-05-26To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Janet Napolitano, J.D.WithholdFOR — 16 of 18 Vanguard fundsAgainstElected, 55.3% support
Harmony Biosciences Holdings, Inc.2026-05-14The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Troy IgnelziForWITHHOLD — 17 of 20 Vanguard fundsForElected, 70.6% support
Bloomin' Brands, Inc.2026-04-22Shareholder Stockholder Proposal Regarding the Issuance of "Blank-Check" Preferred StockAgainstFOR — 14 of 16 Vanguard fundsForApproved, 57.6% support
International Bancshares Corporation2026-05-18ELECTION OF DIRECTORS: D. B. HowlandForAGAINST — 17 of 20 Vanguard fundsForElected, 83.4% support
International Bancshares Corporation2026-05-18ELECTION OF DIRECTORS: D. G. ZunigaForAGAINST — 17 of 20 Vanguard fundsForElected, 87.9% support
International Bancshares Corporation2026-05-18ELECTION OF DIRECTORS: L. A. NortonForAGAINST — 17 of 20 Vanguard fundsForElected, 83.5% support
International Bancshares Corporation2026-05-18ELECTION OF DIRECTORS: R. R. ResendezForAGAINST — 17 of 20 Vanguard fundsForElected, 87.4% support
Banner Corporation2026-05-20Election of twelve directors to each serve for a one-year term: Roberto R. HerenciaForAGAINST — 16 of 19 Vanguard fundsForElected, 82.8% support
Rush Enterprises, Inc.2026-05-19Election of Directors: Dr. Kennon H. GuglielmoForWITHHOLD — 15 of 18 Vanguard fundsForPassed (calculated), 78.3% support
Rush Enterprises, Inc.2026-05-19Election of Directors: Elaine MendozaForWITHHOLD — 15 of 18 Vanguard fundsForPassed (calculated), 67.9% support
Rush Enterprises, Inc.2026-05-19Election of Directors: Raymond J. ChessForWITHHOLD — 15 of 18 Vanguard fundsForPassed (calculated), 77.9% support
Rush Enterprises, Inc.2026-05-19Election of Directors: Troy A. ClarkeForWITHHOLD — 15 of 18 Vanguard fundsForPassed (calculated), 78.3% support
Central Garden & Pet Company2026-02-11Election of Directors: Christopher T. MetzForWITHHOLD — 11 of 13 Vanguard fundsForElected, 64.5% support
Bumble Inc.2026-06-04Approval, on a non-binding advisory basis, of the compensation of the named executive officers as disclosed in the Proxy Statement.ForAGAINST — 11 of 13 Vanguard fundsForApproved, 94.5% support
Blue Owl Capital Inc.2026-06-04Election of Directors: Claudia HolzForAGAINST — 13 of 16 Vanguard fundsForElected, 96.9% support
Blue Owl Capital Inc.2026-06-04Election of Directors: Marc S. LipschultzForAGAINST — 13 of 16 Vanguard fundsForElected, 97.5% support
Blue Owl Capital Inc.2026-06-04Election of Directors: Michael D. ReesForAGAINST — 13 of 16 Vanguard fundsForElected, 97.5% support
Service Corporation International2026-05-06Election of Directors: Anthony L. CoelhoForAGAINST — 14 of 18 Vanguard fundsFor—
Service Corporation International2026-05-06Election of Directors: C. Park ShaperForAGAINST — 14 of 18 Vanguard fundsForPassed (calculated), 82.4% support
Service Corporation International2026-05-06Election of Directors: Marcus A. WattsForAGAINST — 14 of 18 Vanguard fundsForFailed (calculated), 43.5% support
Service Corporation International2026-05-06Election of Directors: Sara Martinez TuckerForAGAINST — 14 of 18 Vanguard fundsForPassed (calculated), 82.6% support
Service Corporation International2026-05-06Election of Directors: Victor L. LundForAGAINST — 14 of 18 Vanguard fundsForPassed (calculated), 79.5% support
Arrowhead Pharmaceuticals, Inc.2026-03-19Advisory Vote to Approve Executive Compensation.ForAGAINST — 18 of 24 Vanguard fundsFor—
AGCO Corporation2026-04-23Shareholder Stockholder proposal regarding giving stockholders an ability to call for a special stockholder meeting, if properly presented at the meeting.ForAGAINST — 16 of 21 Vanguard fundsAgainstFailed (calculated), 48.7% support
Show all 170
Items 26 to 170.
CompanyMeetingItemThis fundMost Vanguard fundsMgmtResult
Douglas Emmett, Inc.2026-05-28Election of eight directors ELECTIONS OF DIRECTORS: Shirley WangForWITHHOLD — 12 of 15 Vanguard fundsForPlurality election, 30.1% support
The Wendy's Company2026-05-20Shareholder Stockholder proposal regarding a restriction on "blank-check" preferred stock, if properly presented at the Annual Meeting.AgainstFOR — 12 of 15 Vanguard fundsForApproved, 51.3% support
Preformed Line Products Company2026-05-04To elect four directors, each for a term expiring in 2028: David C. SunkleAgainstFOR — 10 of 12 Vanguard fundsAgainstElected, 99.9% support
XPEL, Inc.2026-06-10To elect as directors to the XPEL Board of Directors the six nominees named below for a term of one year: Michael A. KlonneWithholdFOR — 10 of 12 Vanguard fundsAgainstPassed (calculated), 83.1% support
XPEL, Inc.2026-06-10To elect as directors to the XPEL Board of Directors the six nominees named below for a term of one year: Richard K. CrumlyWithholdFOR — 10 of 12 Vanguard fundsAgainstPassed (calculated), 70.5% support
XPEL, Inc.2026-06-10To elect as directors to the XPEL Board of Directors the six nominees named below for a term of one year: Stacy L. BogartWithholdFOR — 10 of 12 Vanguard fundsAgainstPassed (calculated), 64.6% support
Ardelyx, Inc.2026-06-16To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares.AgainstFOR — 10 of 12 Vanguard fundsAgainstApproved, 52.6% support
Cogent Communications Holdings, Inc.2026-05-01To approve the Third Amended and Restated 2017 Incentive Award Plan of the Company, including an increase in the number of shares available for issuance thereunder by 1.5 million shares.ForAGAINST — 12 of 15 Vanguard fundsFor—
Enphase Energy, Inc.2026-05-13To elect our three nominees for director named below to hold office as members of the Board of Directors until the 2029 Annual Meeting of the Stockholders: Benjamin KortlangForWITHHOLD — 13 of 17 Vanguard fundsForPlurality election, 43.2% support
Enphase Energy, Inc.2026-05-13To elect our three nominees for director named below to hold office as members of the Board of Directors until the 2029 Annual Meeting of the Stockholders: Jamie HaenggiForWITHHOLD — 13 of 17 Vanguard fundsForPassed (calculated), 83.9% support
Ingles Markets, Incorporated2026-04-30Shareholder Election of Directors: Rory HeldForWITHHOLD — 9 of 11 Vanguard fundsAgainst—
Ingles Markets, Incorporated2026-04-30Election of Directors: Rebekah LoweWithholdFOR — 9 of 11 Vanguard fundsAgainst—
RPC, Inc.2026-04-28To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Amy R. KreislerForAGAINST — 9 of 11 Vanguard fundsForPassed (calculated), 84.8% support
RPC, Inc.2026-04-28To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: John F. WilsonForAGAINST — 9 of 11 Vanguard fundsForPassed (calculated), 89.1% support
RPC, Inc.2026-04-28To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Patrick J. GunningForAGAINST — 9 of 11 Vanguard fundsForPassed (calculated), 90.3% support
RPC, Inc.2026-04-28To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Timothy C. RollinsForAGAINST — 9 of 11 Vanguard fundsForPassed (calculated), 86.4% support
Dream Finders Homes, Inc.2026-06-08Approval of the reincorporation of the Company to the State of Texas by conversion.ForAGAINST — 9 of 11 Vanguard fundsForApproved, 95.3% support
Dream Finders Homes, Inc.2026-06-08Election of Directors: Justin W. UdelhofenAgainstFOR — 9 of 11 Vanguard fundsAgainstElected, 96.0% support
Dream Finders Homes, Inc.2026-06-08Election of Directors: Leonard M. SturmAgainstFOR — 9 of 11 Vanguard fundsAgainstElected, 96.8% support
Dream Finders Homes, Inc.2026-06-08Election of Directors: Megha H. ParekhAgainstFOR — 9 of 11 Vanguard fundsAgainstElected, 95.6% support
Enanta Pharmaceuticals, Inc.2026-03-11To approve an amendment to our 2019 Equity Incentive Plan.ForAGAINST — 9 of 11 Vanguard fundsForApproved, 78.4% support
Corcept Therapeutics Incorporated2026-05-21To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan.AgainstFOR — 14 of 19 Vanguard fundsAgainstApproved, 69.0% support
Avis Budget Group, Inc.2026-05-20Shareholder To vote, on an advisory basis, on a shareholder proposal to request that the Board of Directors take each step necessary so that each voting standard in our charter and bylaws that calls for a greater than simple majority vote be replaced by the applicable majority vote standard and to adjourn the aAgainstFOR — 12 of 16 Vanguard fundsForNot approved, 10.4% support
Freshworks Inc.2026-05-28To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.ForAGAINST — 14 of 19 Vanguard fundsForApproved, 86.9% support
NovoCure Limited2026-06-03The approval of our amended and restated 2024 Omnibus Incentive Plan.AgainstFOR — 12 of 16 Vanguard fundsAgainstApproved, 50.3% support
Syndax Pharmaceuticals, Inc.2026-06-10To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan.AgainstFOR — 10 of 13 Vanguard fundsAgainst—
TeraWulf Inc.2026-06-09The approval, on a non-binding, advisory basis, of the compensation of our named executive officers ("Say-on-Pay"); andForAGAINST — 13 of 18 Vanguard fundsForApproved, 66.1% support
The E.W. Scripps Company2026-05-04Election of Directors: Kim WilliamsForWITHHOLD — 8 of 10 Vanguard fundsFor—
TG Therapeutics, Inc.2026-06-11An advisory vote to approve the compensation of our named executive officers.ForAGAINST — 14 of 20 Vanguard fundsForFailed (calculated), 39.5% support
Fortune Brands Innovations, Inc.2026-05-05Shareholder If properly presented, a stockholder proposal to elect each director annuallyForAGAINST — 11 of 15 Vanguard funds——
Royalty Pharma plc2026-06-04Election of Directors: Vlad Coric, M.D.ForAGAINST — 9 of 12 Vanguard fundsForPassed (calculated), 88.8% support
TPG Inc.2026-06-03Election of Directors: William McRavenForWITHHOLD — 9 of 12 Vanguard fundsForElected, 99.5% support
CNH Industrial N.V.2026-05-08APPOINTMENT OF THE EXECUTIVE DIRECTORS AND APPOINTMENT OF THE NON-EXECUTIVE DIRECTORS: Appointment of Lorenzo SimonelliForAGAINST — 13 of 19 Vanguard fundsForPassed (calculated), 85.1% support
Cogent Communications Holdings, Inc.2026-05-01To hold an advisory vote to approve named executive officer compensation.ForAGAINST — 13 of 19 Vanguard fundsFor—
Wayfair Inc.2026-05-21A non-binding advisory resolution to approve executive compensation.AgainstFOR — 15 of 23 Vanguard fundsAgainstPassed (calculated), 80.3% support
OGE Energy Corp.2026-05-14Shareholder Shareholder Proposal Regarding Simple Majority Vote.AgainstFOR — 10 of 14 Vanguard fundsForPassed (calculated), 79.8% support
OPKO Health, Inc.2026-06-18To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Alice Lin-Tsing Yu, M.D., Ph.D.AgainstFOR — 7 of 9 Vanguard fundsAgainstElected, 90.2% support
OPKO Health, Inc.2026-06-18To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Elias A. Zerhouni, M.D.AgainstFOR — 7 of 9 Vanguard fundsAgainstElected, 90.8% support
OPKO Health, Inc.2026-06-18To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Gary J. Nabel, M.D., Ph.D.AgainstFOR — 7 of 9 Vanguard fundsAgainstElected, 90.6% support
OPKO Health, Inc.2026-06-18To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Jane H. Hsiao, Ph.D., MBAAgainstFOR — 7 of 9 Vanguard fundsAgainstElected, 91.2% support
OPKO Health, Inc.2026-06-18To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: John A. PaganelliAgainstFOR — 7 of 9 Vanguard fundsAgainstElected, 85.8% support
OPKO Health, Inc.2026-06-18To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Phillip Frost, M.D.AgainstFOR — 7 of 9 Vanguard fundsAgainstElected, 91.3% support
OPKO Health, Inc.2026-06-18To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Prem A. Lachman, M.D.AgainstFOR — 7 of 9 Vanguard fundsAgainstElected, 92.4% support
OPKO Health, Inc.2026-06-18To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard C. Pfenniger, Jr.AgainstFOR — 7 of 9 Vanguard fundsAgainstElected, 91.5% support
OPKO Health, Inc.2026-06-18To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Roger J. Medel, M.D.AgainstFOR — 7 of 9 Vanguard fundsAgainstElected, 92.4% support
OPKO Health, Inc.2026-06-18To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven D. RubinAgainstFOR — 7 of 9 Vanguard fundsAgainstElected, 88.2% support
Sana Biotechnology, Inc.2026-06-04To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Alise S. Reicin, M.D.ForWITHHOLD — 7 of 9 Vanguard fundsFor—
Core Scientific, Inc.2026-05-12To approve, on a non-binding, advisory basis, the compensation of our named executive officers.ForAGAINST — 12 of 18 Vanguard fundsForApproved, 63.7% support
XCF Global, Inc.2026-03-06To approve the potential issuance of 19.99% or more of the Company's issued and outstanding Common Stock as of January 26, 2026 pursuant to the private placement offering of shares of Common Stock to a single investor in accordance with Nasdaq Listing Rules 5635(d) and 5635(b)AgainstFOR — 3 of 3 Vanguard fundsAgainst—
XCF Global, Inc.2026-03-06To authorize an adjournment of the meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of Proposal 1AgainstFOR — 3 of 3 Vanguard fundsAgainst—
Roblox Corporation2026-05-28Advisory Vote on the Compensation of our Named Executive Officers.ForAGAINST — 15 of 24 Vanguard fundsForPassed (calculated), 84.2% support
Somnigroup International, Inc.2026-05-13ADVISORY VOTE TO APPROVE THE COMPENSATION OF NAMED EXECUTIVE OFFICERS; ANDForAGAINST — 14 of 22 Vanguard fundsForPassed (calculated), 58.1% support
Enanta Pharmaceuticals, Inc.2026-03-11To elect two Class I directors to serve until the 2029 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Bruce L.A. Carter, Ph.D.ForWITHHOLD — 8 of 11 Vanguard fundsForElected, 81.4% support
Veris Residential, Inc.2026-05-21To approve, by a non-binding advisory vote, the compensation that may be paid or become payable to the Company's named executive officers that is based on or otherwise relates to the Transactions, including the Mergers.AgainstFOR — 13 of 20 Vanguard fundsAgainstNot approved, 44.9% support
GCI Liberty, Inc.2026-05-11The say-on-pay proposal, to approve, on an advisory basis, the compensation of our named executive officers.ForAGAINST — 10 of 15 Vanguard fundsForApproved, 83.1% support
Miami International Holdings, Inc.2026-06-16The election of the 15 director nominees: Talal Jassim Al-BaharWithholdFOR — 6 of 8 Vanguard fundsAgainstPassed (calculated), 75.7% support
Palvella Therapeutics, Inc.2026-06-10Approval of an adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve Proposal 5.AgainstFOR — 6 of 8 Vanguard fundsAgainstPassed (calculated), 75.2% support
Palvella Therapeutics, Inc.2026-06-10Approval of an amendment to the 2024 Equity Incentive Plan to increase the authorized shares issuable under the 2024 Plan by 750,000 shares.AgainstFOR — 6 of 8 Vanguard fundsAgainst—
Vera Therapeutics, Inc.2026-05-21To elect the three Class II directors named below to hold office until the Company's 2029 annual meeting of stockholders: Patrick G. EnrightForWITHHOLD — 6 of 8 Vanguard fundsForElected, 92.5% support
Lakeland Financial Corporation2026-04-14APPROVAL, by non-binding vote, of the Company's compensation of certain executive officers.ForAGAINST — 11 of 17 Vanguard fundsForPassed (calculated), 75.2% support
Ribbon Communications Inc.2026-06-03To approve, on a non-binding, advisory basis, the compensation of Ribbon Communication Inc.'s named executive officers as disclosed in the "Compensation Discussion and Analysis" section and the accompanying compensation tables and related narratives contained in the Proxy Statement.ForAGAINST — 6 of 8 Vanguard fundsForApproved, 69.4% support
NuScale Power Corporation2026-05-29Election of Directors: Stuart HarshawForWITHHOLD — 7 of 10 Vanguard fundsForPassed (calculated), 72.3% support
Enovix Corporation2026-06-11To elect each of the Board of Directors' eight nominees for director named in the accompanying proxy statement, to serve as directors until the 2027 Annual Meeting of Stockholders: Thurman John RodgersForWITHHOLD — 7 of 10 Vanguard fundsForPassed (calculated), 87.0% support
Unisys Corporation2026-04-30Election of Directors: Matthew J. DeschForAGAINST — 7 of 10 Vanguard fundsForPassed (calculated), 62.4% support
CuriosityStream Inc.2026-05-20To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the Proxy Statement.ForAGAINST — 7 of 10 Vanguard fundsForPassed (calculated), 91.2% support
Snowflake Inc.2026-06-29Shareholder To consider and vote on, if properly presented at the meeting, a non-binding stockholder proposal requesting majority vote for director elections.ForAGAINST — 14 of 24 Vanguard fundsAgainstApproved, 64.9% support
Twist Bioscience Corporation2026-02-05To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation."ForAGAINST — 10 of 16 Vanguard fundsForApproved, 76.4% support
BellRing Brands, Inc.2026-01-28Election of Directors: Robert V. VitaleForWITHHOLD — 10 of 16 Vanguard fundsForElected, 73.9% support
TTEC Holdings, Inc.2026-05-21The approval of the redomestication of the Company from Delaware to Texas by conversion.ForAGAINST — 4 of 5 Vanguard fundsForApproved, 85.7% support
Liberty Latin America Ltd.2026-06-23To elect Class III members of our board of directors until the 2029 Annual General Meeting of Shareholders or their earlier resignation or removal: Michael T. FriesForWITHHOLD — 4 of 5 Vanguard fundsFor—
Grindr Inc.2026-06-02Election of Directors: Chad CohenWithholdFOR — 5 of 7 Vanguard fundsAgainstElected, 84.4% support
Nabors Industries Ltd.2026-06-02Approval, on a non-binding, advisory basis, of the compensation paid by the Company to its named executive officers.AgainstFOR — 8 of 13 Vanguard fundsAgainstFailed (calculated), 33.8% support
Krispy Kreme, Inc.2026-06-10Shareholder To vote on a stockholder proposal requesting that the Company's governing documents be amended to replace supermajority voting requirements with simple majority voting requirements; andForAGAINST — 5 of 7 Vanguard fundsAgainst—
Alumis Inc.2026-06-30To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: Zhengbin (Bing) Yao, Ph.D.ForWITHHOLD — 5 of 7 Vanguard fundsForPassed (calculated), 84.1% support
Ginkgo Bioworks Holdings, Inc.2026-06-11Advisory vote to approve executive compensation.AgainstFOR — 9 of 15 Vanguard fundsAgainstApproved, 88.4% support
CorMedix Inc.2026-06-23To approve an amendment to our Charter to update the approval process for amendments relating solely to the terms of one or more series of preferred stock by permitting such amendments to be approved by the holders of the applicable series, without a separate vote of common stockholders, to the exteAgainstFOR — 5 of 7 Vanguard fundsAgainstNot approved, 73.9% support
CorMedix Inc.2026-06-23To approve the adjournment of the 2026 Annual Meeting to a later date or dates, if necessary, to permit further solicitation and voting of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No.s 4, 5, 6, 7 or 8.AgainstFOR — 5 of 7 Vanguard fundsAgainst—
United States Antimony Corporation2026-06-12To elect each of the seven directors named in the Proxy Statement for a term of one year: Dr. Blaise AguirreForWITHHOLD — 5 of 7 Vanguard fundsFor—
United States Antimony Corporation2026-06-12To elect each of the seven directors named in the Proxy Statement for a term of one year: Joseph A. CarrabbaForWITHHOLD — 5 of 7 Vanguard fundsFor—
United States Antimony Corporation2026-06-12To elect each of the seven directors named in the Proxy Statement for a term of one year: Michael A. McManusForWITHHOLD — 5 of 7 Vanguard fundsFor—
Agenus Inc.2026-06-16To approve a one-time stock option exchange program under our 2019 EIP, our Amended and Restated 2009 Equity Incentive Plan, and our 2015 Inducement Equity Plan, with premium strike prices applicable to director and executive officer replacement options.AgainstFOR — 5 of 7 Vanguard fundsAgainst—
Apartment Investment and Management Company2026-02-06Compensation Proposal. To approve, on a non-binding, advisory basis, the specified compensation that may be paid or become payable to Aimco's named executive officers in connection with the Plan of Sale and Liquidation.AgainstFOR — 11 of 19 Vanguard fundsAgainst—
Alta Equipment Group Inc.2026-05-29To approve the First Amendment to Alta Equipment Group, Inc 2020 Omnibus Incentive PlanAgainstFOR — 5 of 7 Vanguard fundsAgainstPassed (calculated), 61.6% support
Jefferson Capital, Inc.2026-06-05The election of David Burton, Thomas Harding and Thomas Lydon, Jr. as Class I Directors: David BurtonWithholdFOR — 5 of 7 Vanguard fundsAgainst—
Viant Technology Inc.2026-06-04To elect two Class II directors, to hold office until our Annual Meeting of Stockholders in 2029 and until their successors are duly elected and qualified, or until their earlier death, resignation or removal: Chris VanderhookForWITHHOLD — 5 of 7 Vanguard fundsFor—
AMC Global Media Inc.2026-06-16Election of the following nominees as Directors: Carl E. VogelWithholdFOR — 6 of 9 Vanguard fundsAgainstPlurality election, 26.8% support
AMC Global Media Inc.2026-06-16Election of the following nominees as Directors: Debra G. PerelmanWithholdFOR — 6 of 9 Vanguard fundsAgainstPassed (calculated), 55.7% support
AMC Global Media Inc.2026-06-16Election of the following nominees as Directors: Matthew C. BlankWithholdFOR — 6 of 9 Vanguard fundsAgainstPassed (calculated), 55.6% support
Niagen Bioscience, Inc.2026-06-24Election of Directors: Hamed ShahbaziWithholdFOR — 6 of 9 Vanguard fundsAgainstElected, 67.4% support
Miami International Holdings, Inc.2026-06-16The approval, on a non-binding advisory basis, of the compensation of our named executive officers.ForAGAINST — 7 of 12 Vanguard fundsForPassed (calculated), 73.9% support
Strata Critical Medical, Inc.2026-05-28Advisory Vote on the Compensation of our Named Executive Officers.ForAGAINST — 5 of 8 Vanguard fundsForApproved, 82.8% support
Immersion Corporation2026-04-06Advisory vote to approve the compensation of our named executive officers.ForAGAINST — 5 of 8 Vanguard fundsForPassed (calculated), 56.8% support
Definitive Healthcare Corp.2026-06-04To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in this Proxy Statement.ForAGAINST — 5 of 8 Vanguard fundsForApproved, 89.6% support
Open Lending Corporation2026-06-03To approve, on a nonbinding advisory basis, the compensation of our named executive officersForAGAINST — 5 of 8 Vanguard fundsForApproved, 67.9% support
TPG RE Finance Trust, Inc.2026-05-19Election of Directors: Bradley SmithForWITHHOLD — 4 of 6 Vanguard fundsForPassed (calculated), 76.7% support
TPG RE Finance Trust, Inc.2026-05-19Election of Directors: Michael GillmoreForWITHHOLD — 4 of 6 Vanguard fundsForPassed (calculated), 80.4% support
TPG RE Finance Trust, Inc.2026-05-19Election of Directors: Todd SchusterForWITHHOLD — 4 of 6 Vanguard fundsForPassed (calculated), 95.1% support
TPG RE Finance Trust, Inc.2026-05-19Election of Directors: Wendy SilversteinForWITHHOLD — 4 of 6 Vanguard fundsForPassed (calculated), 94.6% support
TPG RE Finance Trust, Inc.2026-05-19Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.ForAGAINST — 4 of 6 Vanguard fundsForPassed (calculated), 85.9% support
Dave & Buster's Entertainment, Inc.2026-06-18Election of Directors: Scott I. RossAgainstFOR — 4 of 6 Vanguard fundsAgainstFailed (calculated), 45.1% support
Maui Land & Pineapple Company, Inc.2026-05-27Election of Directors: To elect seven directors to serve for a one-year term to expire at the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: A. Catherine NgoWithholdFOR — 4 of 6 Vanguard fundsAgainstPassed (calculated), 91.9% support
Maui Land & Pineapple Company, Inc.2026-05-27Election of Directors: To elect seven directors to serve for a one-year term to expire at the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Glyn AeppelWithholdFOR — 4 of 6 Vanguard fundsAgainstPassed (calculated), 92.5% support
Maui Land & Pineapple Company, Inc.2026-05-27Election of Directors: To elect seven directors to serve for a one-year term to expire at the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Ken OtaWithholdFOR — 4 of 6 Vanguard fundsAgainstPassed (calculated), 92.5% support
Rithm Property Trust Inc.2026-06-02Election of Directors: Daniel HoffmanForWITHHOLD — 3 of 4 Vanguard fundsForPlurality election, 46.3% support
Rithm Property Trust Inc.2026-06-02Election of Directors: Mary HaggertyForWITHHOLD — 3 of 4 Vanguard fundsForPassed (calculated), 51.7% support
Rithm Property Trust Inc.2026-06-02Election of Directors: Michael NierenbergForWITHHOLD — 3 of 4 Vanguard fundsForPassed (calculated), 58.5% support
Rithm Property Trust Inc.2026-06-02Election of Directors: Paul FriedmanForWITHHOLD — 3 of 4 Vanguard fundsForPassed (calculated), 53.1% support
Travelzoo2026-04-20Vote to approve option grant to General Manager, U.S.ForAGAINST — 3 of 4 Vanguard fundsFor—
Travelzoo2026-04-20Vote to approve option grant to Head of Engineering.ForAGAINST — 3 of 4 Vanguard fundsFor—
Faraday Future Intelligent Electric Inc.2026-02-13To approve one or more adjournments of the Special Meeting by the Company from time to time to permit further solicitation of proxies, if necessary or appropriate, if sufficient votes are not represented at the Special Meeting to approve one or more Proposals at the time of such adjournment or if otAgainstFOR — 4 of 6 Vanguard fundsAgainstApproved, 86.4% support
Faraday Future Intelligent Electric Inc.2026-02-13To approve the Company's Third Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's Class A common stock, par value $0.0001 per share, and Class B common stock, par value $0.0001 per share, by 79,814,454, from 232,470,985 to 312,AgainstFOR — 4 of 6 Vanguard fundsAgainstApproved, 75.7% support
BioAge Labs, Inc.2026-06-10To elect three Class II directors, to serve a three-year term through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Patrick EnrightForWITHHOLD — 4 of 6 Vanguard fundsFor—
Eledon Pharmaceuticals, Inc.2026-06-18Election of Class III Directors: James RobinsonForWITHHOLD — 4 of 6 Vanguard fundsFor—
New Fortress Energy Inc.2026-06-17Conditioned upon the receipt of the requisite vote on Proposals 3a through 3g, to approve the proposed amended certificate of incorporation, in the form attached to this Proxy Statement as Annex A (the "Amended Certificate of Incorporation"), which includes the approval of all other changes in the AForAGAINST — 4 of 6 Vanguard fundsFor—
New Fortress Energy Inc.2026-06-17Election of Class I Directors: Charles M. SledgeForWITHHOLD — 4 of 6 Vanguard fundsFor—
New Fortress Energy Inc.2026-06-17Election of Class I Directors: Katherine E. WannerForWITHHOLD — 4 of 6 Vanguard fundsFor—
New Fortress Energy Inc.2026-06-17To amend the Certificate of Incorporation to provide that holders of shares of Class A common stock of the Company will not be entitled to vote on any amendment to the Certificate of Incorporation (including any certificate of designations and any other applicable designation of capital stock) that ForAGAINST — 4 of 6 Vanguard fundsFor—
Skywater Technology, Inc.2026-06-10Election of Directors: Andrew D. C. LaFrenceWithholdFOR — 4 of 6 Vanguard fundsAgainstPassed (calculated), 93.2% support
Skywater Technology, Inc.2026-06-10Election of Directors: Dennis J. GoetzWithholdFOR — 4 of 6 Vanguard fundsAgainstPassed (calculated), 59.2% support
Skywater Technology, Inc.2026-06-10Election of Directors: Tammy J. MillerWithholdFOR — 4 of 6 Vanguard fundsAgainstPassed (calculated), 92.9% support
Skywater Technology, Inc.2026-06-10Election of Directors: Timothy E. BaxterWithholdFOR — 4 of 6 Vanguard fundsAgainstPassed (calculated), 92.4% support
Grindr Inc.2026-06-02To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.ForAGAINST — 6 of 11 Vanguard fundsForPassed (calculated), 79.2% support
Quantum-Si Incorporated2026-05-15To approve, by a non-binding, advisory vote, the compensation of our named executive officers, as disclosed in this proxy statementForAGAINST — 5 of 9 Vanguard fundsFor—
Calavo Growers, Inc.2026-04-28The Merger-Related Compensation Proposal - A non-binding, advisory proposal to approve compensation that will or may become payable by Calavo to its named executive officers in connection with the transactions contemplated by the Merger Agreement.AgainstFOR — 5 of 9 Vanguard fundsAgainstNot approved, 40.8% support
Bally's Corporation2026-05-19Approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.ForAGAINST — 4 of 7 Vanguard fundsForPassed (calculated), 99.1% support
NRC Health2026-06-23NON-BINDING, ADVISORY VOTE ON THE APPROVAL OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.ForAGAINST — 4 of 7 Vanguard fundsForApproved, 85.5% support
JAKKS Pacific, Inc.2026-06-05To conduct an advisory vote on executive compensation.AgainstFOR — 4 of 7 Vanguard fundsAgainstNot approved, 47.6% support
Teads Holding Co.2026-05-14Approve, on an advisory basis, the compensation of our named executive officers, described in the proxy statement.ForAGAINST — 4 of 7 Vanguard fundsForPassed (calculated), 88.6% support
Universal Logistics Holdings, Inc.2026-04-29To elect 9 directors for the coming year: Clarence W. GoodenWithholdFOR — 3 of 5 Vanguard fundsAgainstPassed (calculated), 98.4% support
Universal Logistics Holdings, Inc.2026-04-29To elect 9 directors for the coming year: Frederick P. CalderoneWithholdFOR — 3 of 5 Vanguard fundsAgainstPassed (calculated), 79.7% support
Universal Logistics Holdings, Inc.2026-04-29To elect 9 directors for the coming year: Grant E. BelangerWithholdFOR — 3 of 5 Vanguard fundsAgainstPassed (calculated), 92.2% support
Universal Logistics Holdings, Inc.2026-04-29To elect 9 directors for the coming year: H.E. "Scott" WolfeWithholdFOR — 3 of 5 Vanguard fundsAgainstPassed (calculated), 79.7% support
Universal Logistics Holdings, Inc.2026-04-29To elect 9 directors for the coming year: Marcus D. HudsonWithholdFOR — 3 of 5 Vanguard fundsAgainstPassed (calculated), 92.8% support
Universal Logistics Holdings, Inc.2026-04-29To elect 9 directors for the coming year: Matthew J. MorounWithholdFOR — 3 of 5 Vanguard fundsAgainst—
Universal Logistics Holdings, Inc.2026-04-29To elect 9 directors for the coming year: Michael A. ReganWithholdFOR — 3 of 5 Vanguard fundsAgainstPassed (calculated), 97.4% support
NRC Health2026-06-23APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO CHANGE THE VOTING REQUIREMENT FOR STOCKHOLDER ACTION BY WRITTEN CONSENT IN LIEU OF A MEETING FROM UNANIMOUS TO THE VOTING POWER THAT WOULD BE REQUIRED TO GIVE EFFECT TO THE ACTION IF IT WERE APPROVED AT A MEETING, ALONG WITH CERTAIN CLAForAGAINST — 3 of 5 Vanguard fundsForApproved, 94.8% support
NRC Health2026-06-23APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO REMOVE CERTAIN SUPERMAJORITY VOTING REQUIREMENTS IN ARTICLE 6 OF OUR CERTIFICATE OF INCORPORATION, ALONG WITH CERTAIN CLARIFYING, CONFORMING, AND MINISTERIAL CHANGES.ForAGAINST — 3 of 5 Vanguard fundsForApproved, 95.1% support
Clarus Corporation2026-05-28To elect the five nominees named in the accompanying Proxy Statement to serve on the Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified: Nicholas SokolowForWITHHOLD — 3 of 5 Vanguard fundsForPassed (calculated), 74.3% support
Clarus Corporation2026-05-28To elect the five nominees named in the accompanying Proxy Statement to serve on the Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified: Roger WernerForWITHHOLD — 3 of 5 Vanguard fundsForPassed (calculated), 79.9% support
eHealth, Inc.2026-06-18Election of Class II Directors: Beth A. BrookeForWITHHOLD — 3 of 5 Vanguard fundsForPassed (calculated), 82.3% support
Faraday Future Intelligent Electric Inc.2026-05-22Approval of one or more adjournments of the Annual Meeting by the Company from time to time to permit further solicitation of proxies, if necessary or appropriate, if sufficient votes are not represented at the Annual Meeting to approve one or more Proposals at the time of such adjournment or if othAgainstFOR — 3 of 5 Vanguard fundsAgainstApproved, 88.4% support
Faraday Future Intelligent Electric Inc.2026-05-22To approve an amendment to the Company's Third Amended and Restated Certificate of Incorporation, as amended (the "Charter"), to increase (i) the number of authorized shares of the Company's Class A Common Stock, and Class B common stock, par value $0.0001 per share (the "Class B Common Stock," and,AgainstFOR — 3 of 5 Vanguard fundsAgainstApproved, 80.0% support
BRC Inc.2026-05-28Election of Class I Directors: Lawrence "Chip" MolloyForAGAINST — 3 of 5 Vanguard fundsFor—
New Fortress Energy Inc.2026-06-17To adjourn the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies if there are insufficient votes to approve any of Proposals 1, 2, 3a through 3h, 4 and 5 at the time of the Annual Meeting.ForAGAINST — 3 of 5 Vanguard fundsFor—
INmune Bio Inc.2026-06-16To elect the five directors set forth below to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Timothy SchroederForWITHHOLD — 2 of 3 Vanguard fundsFor—

Download all 170 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 77.7% of this fund’s 45,580 such votes could be given a sector; the other 10,154 (22.3%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance8,1882,17926.6%
Consumer Discretionary7,1921,52321.2%
Health Care5,14890017.5%
Industrials4,6241,01021.8%
Technology3,61361717.1%
Real Estate2,31858925.4%
Energy1,41528219.9%
Utilities99323423.6%
Consumer Staples69612117.4%
Basic Materials4479821.9%
Miscellaneous4278219.2%
Telecommunications3655414.8%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections39,7738,517
Audit-related3,53999
Say-on-Pay3,2920
Compensation1,50698
Capital Structure1,14058
Corporate Governance1,140110
Extraordinary Transactions38639
Shareholder Rights and Defenses1187
Environment or Climate1212
Other Social Issues97

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Snowflake Inc.July 2, 2025$2.9B70
Marvell Technology, Inc.June 25, 2026$2.8B269
Sandisk CorporationNovember 18, 2025$2.4B100
Snowflake Inc.June 29, 2026$2.2B123
Cloudflare, Inc.June 30, 2026$2.1B240
Cheniere Energy, Inc.May 14, 2026$1.5B209
Ferguson Enterprises Inc.April 30, 2026$1.1B240
Ferguson Enterprises Inc.December 3, 2025$1.1B130

Notable votes against management

MeetingCompanyProposalFundMgmt
June 25, 2026Marvell Technology, Inc.To consider and act on one stockholder proposal, entitled "Independent Board Chairman", if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
June 29, 2026Snowflake Inc.To consider and vote on, if properly presented at the meeting, a non-binding stockholder proposal requesting majority vote for director elections. Shareholder proposalForAgainst
September 3, 2025Casey's General Stores, Inc.Shareholder proposal regarding Scope 3 greenhouse gas reduction targets. Shareholder proposalAgainstFor
May 20, 2026Markel Group Inc.Shareholder proposal for a report on the Company's strategies and action plans to mitigate material environmental risks. Shareholder proposalAgainstFor
May 20, 2026Markel Group Inc.Shareholder proposal to give shareholders an ability to call for a special shareholder meeting. Shareholder proposalAgainstFor
May 4, 2026First Citizens BancShares, Inc.Proposal requesting a report on faith-based employee resource groups. Shareholder proposalAgainstFor
May 20, 2026Reliance, Inc.To consider a stockholder proposal requiring any director who fails to receive a majority vote to leave the board of directors within nine months. Shareholder proposalAgainstFor
May 6, 2026Entegris, Inc.Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposalAgainstFor
January 12, 2026Zscaler, Inc.To vote on a non-binding stockholder proposal requesting the declassification of our board of directors. Shareholder proposalForAgainst
May 20, 2026REINSURANCE GROUP OF AMERICA, INC.Election of Director: Peter BabejForAgainst
May 20, 2026REINSURANCE GROUP OF AMERICA, INC.Election of Director: Michele BangForAgainst
June 1, 2026DocuSign, Inc.A stockholder proposal to report on the risks of non-fiduciary executive compensation metrics, if properly presented at the meeting Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (17 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

50,924 ballot items at 3,621 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Vanguard Extended Market Index Fund (VXF) voted at 3,621 shareholder meetings of 3,259 companies, on 50,924 ballot items in all. Where management made a recommendation, the fund followed it on 78.8% of the items and voted against it 8,953 times. Its most frequent area of disagreement was director elections (8,517 of its votes against management). It voted FOR 22.1% of the 113 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than Vanguard's funds as a whole (91.5% against 94.5%). It voted differently from most Vanguard funds on 170 items. 17 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Vanguard’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.